Development of a preventive vaccine for Ebola virus infection in primates

Nancy J. Sullivan, Anthony Sanchez, Pierre E. Rollin, Zhi-yong Yang and Gary J. Nabel ()
Additional contact information
Nancy J. Sullivan: Vaccine Research Center, National Institutes of Health
Anthony Sanchez: Special Pathogens Branch, Centers for Disease Control and Prevention
Pierre E. Rollin: Special Pathogens Branch, Centers for Disease Control and Prevention
Zhi-yong Yang: Vaccine Research Center, National Institutes of Health
Gary J. Nabel: Vaccine Research Center, National Institutes of Health

Nature, 2000, vol. 408, issue 6812, 605-609

Abstract: Abstract Outbreaks of haemorrhagic fever caused by the Ebola virus are associated with high mortality rates that are a distinguishing feature of this human pathogen. The highest lethality is associated with the Zaire subtype, one of four strains identified to date1,2. Its rapid progression allows little opportunity to develop natural immunity, and there is currently no effective anti-viral therapy. Therefore, vaccination offers a promising intervention to prevent infection and limit spread. Here we describe a highly effective vaccine strategy for Ebola virus infection in non-human primates. A combination of DNA immunization and boosting with adenoviral vectors that encode viral proteins generated cellular and humoral immunity in cynomolgus macaques. Challenge with a lethal dose of the highly pathogenic, wild-type, 1976 Mayinga strain of Ebola Zaire virus resulted in uniform infection in controls, who progressed to a moribund state and death in less than one week. In contrast, all vaccinated animals were asymptomatic for more than six months, with no detectable virus after the initial challenge. These findings demonstrate that it is possible to develop a preventive vaccine against Ebola virus infection in primates.

Date: 2000
References: Add references at CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
https://www.nature.com/articles/35046108 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:408:y:2000:i:6812:d:10.1038_35046108

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35046108

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().